Author - Ziad

CTERA Announces Strategic Partnership with Wasabi Technologies to Bring Secure Cloud File Services to the Mid-Market

CTERA, the leader in edge-to-cloud file services, today announced a new partnership with Wasabi Technologies, the hot cloud storage company, to provide integrated file and object data service for mid-sized companies. The new offering combines CTERA’s global file system technology with Wasabi’s scalable and cost-effective object storage, in simple service bundles designed for rapid delivery and support by channel partners. Companies of all sizes struggle to close IT gaps as they shift from traditional workplace models to new post-pandemic hybrid...
Read more...

SOM Picks Aircuity Platform For New 7 World Trade Center HQ

Global architectural firm Skidmore, Owings & Merrill (SOM) has installed the Aircuity ventilation optimization platform in its new headquarters at 7 World Trade Center (WTC) in New York City. SOM selected the Aircuity platform for its ability to optimize ventilation and deliver a healthier and more productive indoor environment, along with Aircuity’s continuous indoor air quality (IAQ) analytics that provided key health and safety insight when moving into the space during the pandemic. Read more >>
Read more...

Educational Service Centers of Indiana Partners with Scrible to Help Indiana Schools Affordably Access its Research and Writing Super App

Scrible, the super app that streamlines the research and writing process for students and educators, announced today its new partnership with the Educational Service Centers of Indiana (ESC of I) to provide its members access to its platform at a considerable discount. ESC of I is a collaborative of Indiana's nine individual Education Service Centers (ESCs). Read more >>
Read more...

OmniLife Named Winner of the 2022 Lyfebulb-CVS Kidney Care® Innovation Challenge

Lyfebulb, a patient-empowerment platform that connects patients with industry experts to support user-driven innovation, and CVS Kidney Care®, a CVS Health® company, are excited to announce that OmniLife was selected as the winner, and Kindness for Kidneys International received an honorable mention, at the 2022 Lyfebulb–CVS Kidney Care® Innovation Challenge: Accelerating Innovations in Kidney Disease to Improve Health Equity and Outcomes. Read more >>
Read more...

CleanFiber secures $14 million for Lackawanna expansion

A past 43North winner is expanding again after securing $14 million in debt financing. Five years after the company moved to Buffalo, CleanFiber now employs more than 70 people in its Lackawanna factory. The funding will support the addition of new equipment that allows the company to fulfill the demand for its product. “We’ve had a significant uptick in hiring that’s been driven by growth and demand,” CEO Jonathan Strimling said. “We have a long backlog of demand for our...
Read more...

Michael Bayer: ‘CFOs Are Storytellers’

Michael Bayer, CFO of Wasabi Technologies, asked this rhetorical question in response to CFO’s inquiry about the business outlook for his company and cloud storage. In preparation for this week’s CFO Leadership Council Conference, we took the opportunity to ask Bayer to reflect on his own career in finance and how his organizational structure empowers Wasabi to greater opportunities. Read more >>
Read more...

A Founder Focused Approach

We focus on and celebrate Boston Harbor Angels Founders!             A seasoned serial founder once said, "If it feels easy it means you are doing something wrong" , building a business and being accountable to investors is very hard and that is why the success and exit rates are so low. Aligning yourself with the right #AngelInvestors is key and keeping them updated makes the journey much simpler. Angels are here to help! Boston Harbor Angels fund and support dozens of Founders! There is nothing more...
Read more...

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today it dosed the first set of volunteers in an open-label study of AKS-452, its protein subunit COVID-19 vaccine, as a booster. The Phase II booster study is designed to investigate the response of the immune system in up to 600 volunteers who have previously been vaccinated with EMA-registered vaccines from Pfizer, Moderna, Johnson & Johnson (Janssen) and AstraZeneca. The study is being conducted at the University Medical...
Read more...

US Veterans and Injured Workers Find Injury Solution With sam® Sustained Acoustic Medicine Treatment

Sustained acoustic medicine, or sam®, is a non-invasive ultrasound device from ZetrOZ Systems used to treat soft tissue injuries and arthritis. The U.S. Federal Drug Administration cleared sam® for clinical use in 2013, but many health care providers are just now discovering the many benefits it provides to treatment and recovery efforts. The sam® pain relief device has helped thousands of patients, including U.S. Veterans and Active Duty Members, regain mobility and reduce pain from common overuse injuries and osteoarthritis....
Read more...